Mayo Clinic: Brain Neoplasms trials

The registry lists 27 Brain Neoplasms studies with Mayo Clinic as lead sponsor. 13 are open to participants now and 0 have results posted.

Early Phase 1 2Phase 1 4Phase 2 4Phase 3 1No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain TumorsRecruitingNCT07174661Not applicable
• Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative DiseasesRecruitingNCT06788886Not applicable
• An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain TumorsRecruitingNCT06667726Phase 2
• Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness MeasurementsNot yet recruitingNCT06630338
• Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain TumorsRecruitingNCT06322602Not applicable
• Extracellular Impact of Ultrasound-induced Blood-brain Barrier DisruptionRecruitingNCT05733312Not applicable
• SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE TrialRecruitingNCT05222620Phase 2
• Surgical Resection of Latent Brain Tumors Prior to RecurrenceRecruitingNCT04810871Not applicable
• Ommaya Reservoir Placement for Brain Tumor Biomarker AccessRecruitingNCT04692337Not applicable
• Cancer Genetic Testing in Ethnic PopulationsRecruitingNCT04475640Not applicable
• Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System LesionsRecruitingNCT04047264Not applicable
• Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
• Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain TumorsRecruitingNCT03750227Phase 3
• Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional RecoveryActive, not recruitingNCT07091396Not applicable
• Defining Musical Toxicity and Its Effect on Patient Well-beingWithdrawnNCT06494046
• Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation TherapyActive, not recruitingNCT06377696Phase 2
• CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery to Improve Treatment of Melanoma Brain MetastasesSuspendedNCT05669352Phase 1/2
• E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic MelanomaTerminatedNCT05388877Phase 1
• Handheld Dynamometer During Awake Craniotomy PilotCompletedNCT04742231Not applicable
• 18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the BrainTerminatedNCT04462419
• Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit StudyCompletedNCT04456140Phase 1
• Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerCompletedNCT04067960Early Phase 1
• Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor PatientsCompletedNCT03090386
• Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing SurgeryCompletedNCT03071913
• Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain TumorsCompletedNCT02444546Phase 1
• 18F-DOPA-PET in Planning Surgery in Patients with GliomasCompletedNCT02020720Early Phase 1
• Assessing the Patient Experience in Cancer CareCompletedNCT01621295